Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Agitation and impulsivity in mid and late life as possible risk markers for incident dementia

DR. Bateman, S. Gill, S. Hu, ED. Foster, MT. Ruthirakuhan, AF. Sellek, ME. Mortby, V. Matušková, KP. Ng, RM. Tarawneh, Y. Freund-Levi, S. Kumar, S. Gauthier, PB. Rosenberg, F. Ferreira de Oliveira, DP. Devanand, C. Ballard, Z. Ismail,...

. 2020 ; 6 (1) : e12016. [pub] 20200906

Language English Country United States

Document type Journal Article, Review

Persistent link   https://www.medvik.cz/link/bmc21002091

Grant support
K23 AG059914 NIA NIH HHS - United States
R01 AG049872 NIA NIH HHS - United States
R01 AG054771 NIA NIH HHS - United States

To identify knowledge gaps regarding new-onset agitation and impulsivity prior to onset of cognitive impairment or dementia the International Society to Advance Alzheimer's Research and Treatment Neuropsychiatric Syndromes (NPS) Professional Interest Area conducted a scoping review. Extending a series of reviews exploring the pre-dementia risk syndrome Mild Behavioral Impairment (MBI), we focused on late-onset agitation and impulsivity (the MBI impulse dyscontrol domain) and risk of incident cognitive decline and dementia. This scoping review of agitation and impulsivity pre-dementia syndromes summarizes the current biomedical literature in terms of epidemiology, diagnosis and measurement, neurobiology, neuroimaging, biomarkers, course and prognosis, treatment, and ongoing clinical trials. Validations for pre-dementia scales such as the MBI Checklist, and incorporation into longitudinal and intervention trials, are needed to better understand impulse dyscontrol as a risk factor for mild cognitive impairment and dementia.

Center for Alzheimer Research Division of Clinical Geriatrics Department of Neurobiology Care Sciences and Society Karolinska Institute Stockholm Sweden School of Medical Sciences Örebro University Örebro Sweden

Centre for Addiction and Mental Health Toronto Ontario Canada Department of Psychiatry University of Toronto Ontario Canada

College of Medicine and Health The University of Exeter Exeter UK

Community Health Sciences and O'Brien Institute for Public Health University of Calgary Calgary Alberta Canada

Department of Clinical Neurosciences

Department of Neurology and Neurosurgery Escola Paulista de Medicina Federal University of São Paulo São Paulo São Paulo Brazil

Department of Neurology College of Medicine The Ohio State University Columbus Ohio USA

Department of Neurology National Neuroscience Institute Singapore Singapore

Department of Psychiatry Indiana University School of Medicine Indianapolis Indiana Indiana University Center for Aging Research Regenstrief Institute Indianapolis Indiana

Division of Geriatric Psychiatry and Neuropsychiatry Department of Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine Baltimore Maryland

Hotchkiss Brain Institute University of Calgary Calgary Alberta Canada

Hotchkiss Brain Institute University of Calgary Calgary Alberta Canada Community Health Sciences and O'Brien Institute for Public Health University of Calgary Calgary Alberta Canada Department of Psychiatry and the Mathison Centre for Mental Health Research and Education Cumming School of Medicine University of Calgary Calgary Alberta Canada

Hurvitz Brain Sciences Research Program Sunnybrook Research Institute Toronto Ontario Canada Department of Pharmacology and Toxicology University of Toronto Ontario Canada

International Clinical Research Center St Anne's University Hospital Brno Brno Czech Republic Memory Disorders Clinic Department of Neurology 2nd Faculty of Medicine Charles University Prague and Motol University Hospital Prague Czech Republic

McGill Center for Studies in Aging McGill University Montreal Quebec Canada

New York State Psychiatric Institute and Department of Psychiatry and Department of Psychiatry College of Physicians and Surgeons Columbia University New York New York

Ruth Lilly Medical Library Indiana University School of Medicine Indianapolis Indiana University of California Berkeley Berkeley CA

School of Psychology University of New South Wales Sydney New South Wales Australia Neuroscience Research Australia University of New South Wales Sydney New South Wales Australia

The Alzheimer Foundation of Costa Rica Costa Rica

the Ron and Rene Ward Centre for Healthy Brain Aging Research

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21002091
003      
CZ-PrNML
005      
20210126092847.0
007      
ta
008      
210105s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/trc2.12016 $2 doi
035    __
$a (PubMed)32995467
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Bateman, Daniel R $u Department of Psychiatry Indiana University School of Medicine Indianapolis Indiana. Indiana University Center for Aging Research Regenstrief Institute Indianapolis Indiana.
245    10
$a Agitation and impulsivity in mid and late life as possible risk markers for incident dementia. / $c DR. Bateman, S. Gill, S. Hu, ED. Foster, MT. Ruthirakuhan, AF. Sellek, ME. Mortby, V. Matušková, KP. Ng, RM. Tarawneh, Y. Freund-Levi, S. Kumar, S. Gauthier, PB. Rosenberg, F. Ferreira de Oliveira, DP. Devanand, C. Ballard, Z. Ismail, International Society to Advance Alzheimer's Research and Treatment (ISTAART), Neuropsychiatric Syndromes Professional Interest Area (NPS-PIA),
520    9_
$a To identify knowledge gaps regarding new-onset agitation and impulsivity prior to onset of cognitive impairment or dementia the International Society to Advance Alzheimer's Research and Treatment Neuropsychiatric Syndromes (NPS) Professional Interest Area conducted a scoping review. Extending a series of reviews exploring the pre-dementia risk syndrome Mild Behavioral Impairment (MBI), we focused on late-onset agitation and impulsivity (the MBI impulse dyscontrol domain) and risk of incident cognitive decline and dementia. This scoping review of agitation and impulsivity pre-dementia syndromes summarizes the current biomedical literature in terms of epidemiology, diagnosis and measurement, neurobiology, neuroimaging, biomarkers, course and prognosis, treatment, and ongoing clinical trials. Validations for pre-dementia scales such as the MBI Checklist, and incorporation into longitudinal and intervention trials, are needed to better understand impulse dyscontrol as a risk factor for mild cognitive impairment and dementia.
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Gill, Sascha $u Department of Clinical Neurosciences; and the Ron and Rene Ward Centre for Healthy Brain Aging Research; Hotchkiss Brain Institute University of Calgary Calgary Alberta Canada.
700    1_
$a Hu, Sophie $u Community Health Sciences, and O'Brien Institute for Public Health University of Calgary Calgary Alberta Canada.
700    1_
$a Foster, Erin D $u Ruth Lilly Medical Library Indiana University School of Medicine Indianapolis Indiana. University of California Berkeley Berkeley CA.
700    1_
$a Ruthirakuhan, Myuri T $u Hurvitz Brain Sciences Research Program Sunnybrook Research Institute Toronto Ontario Canada. Department of Pharmacology and Toxicology University of Toronto Ontario Canada.
700    1_
$a Sellek, Allis F $u The Alzheimer Foundation of Costa Rica Costa Rica.
700    1_
$a Mortby, Moyra E $u School of Psychology University of New South Wales Sydney New South Wales Australia. Neuroscience Research Australia University of New South Wales Sydney New South Wales Australia.
700    1_
$a Matušková, Veronika $u International Clinical Research Center St. Anne's University Hospital Brno Brno Czech Republic. Memory Disorders Clinic, Department of Neurology, 2nd Faculty of Medicine Charles University in Prague and Motol University Hospital Prague Czech Republic.
700    1_
$a Ng, Kok Pin $u Department of Neurology National Neuroscience Institute Singapore Singapore.
700    1_
$a Tarawneh, Rawan M $u Department of Neurology, College of Medicine The Ohio State University Columbus Ohio USA.
700    1_
$a Freund-Levi, Yvonne $u Center for Alzheimer Research, Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society Karolinska Institute Stockholm Sweden. School of Medical Sciences Örebro University Örebro Sweden.
700    1_
$a Kumar, Sanjeev $u Centre for Addiction and Mental Health Toronto Ontario Canada. Department of Psychiatry University of Toronto Ontario Canada.
700    1_
$a Gauthier, Serge $u McGill Center for Studies in Aging McGill University Montreal Quebec Canada.
700    1_
$a Rosenberg, Paul B $u Division of Geriatric Psychiatry and Neuropsychiatry, Department of Psychiatry and Behavioral, Sciences Johns Hopkins University School of Medicine Baltimore Maryland.
700    1_
$a Ferreira de Oliveira, Fabricio $u Department of Neurology and Neurosurgery, Escola Paulista de Medicina Federal University of São Paulo (UNIFESP), São Paulo São Paulo Brazil.
700    1_
$a Devanand, D P $u New York State Psychiatric Institute and Department of Psychiatry and Department of Psychiatry, College of Physicians and Surgeons Columbia University New York New York.
700    1_
$a Ballard, Clive $u College of Medicine and Health The University of Exeter Exeter UK.
700    1_
$a Ismail, Zahinoor $u Department of Clinical Neurosciences; and the Ron and Rene Ward Centre for Healthy Brain Aging Research; Hotchkiss Brain Institute University of Calgary Calgary Alberta Canada. Community Health Sciences, and O'Brien Institute for Public Health University of Calgary Calgary Alberta Canada. Department of Psychiatry, and the Mathison Centre for Mental Health Research & Education Cumming School of Medicine, University of Calgary Calgary Alberta Canada.
710    2_
$a International Society to Advance Alzheimer's Research and Treatment (ISTAART), Neuropsychiatric Syndromes Professional Interest Area (NPS-PIA)
773    0_
$w MED00205981 $t Alzheimer's & dementia (New York, N. Y.) $x 2352-8737 $g Roč. 6, č. 1 (2020), s. e12016
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32995467 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210126092842 $b ABA008
999    __
$a ind $b bmc $g 1614159 $s 1122375
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 6 $c 1 $d e12016 $e 20200906 $i 2352-8737 $m Alzheimer's & dementia $n Alzheimers Dement (N Y) $x MED00205981
GRA    __
$a K23 AG059914 $p NIA NIH HHS $2 United States
GRA    __
$a R01 AG049872 $p NIA NIH HHS $2 United States
GRA    __
$a R01 AG054771 $p NIA NIH HHS $2 United States
LZP    __
$a Pubmed-20210105
Back

Find record

Citation metrics

Archiving options